IP Library Granted Patent US 11,166,935
Granted Patent B2
US 11,166,935 · App. 16/626,166 · Granted Nov 9, 2021

Cannabinoid pouch

Inventor: Heidi Ziegler Bruun (Vejle Ost, DK)
A61K31/352A61K9/009A61K9/0056A61K31/05A61K47/12A61K47/26
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,166,935
App. No.
16/626,166
Granted
Nov 9, 2021
Kind
B2
Abstract

A pouch designed for administration of an active ingredient in the oral cavity is disclosed, the pouch containing an amount of one or more cannabinoids. Also, pouches for use as a medicament, for use in alleviation of pain, and for use in mitigation of appetite deficiency are disclosed. Further, a method of alleviation of pain and a method of mitigation of appetite deficiency using the pouch are disclosed.

Claims (29)

1. A pouch designed for administration of an active ingredient in the oral cavity, the pouch containing a matrix composition comprising:

powdered granules comprising

one or more cannabinoids and

a water soluble composition, wherein the one or more cannabinoids is released from the matrix composition within 10 minutes.

2. The pouch according to claim 1 , wherein the water-soluble composition comprises a water-soluble carrier.

3. The pouch according to claim 1 , wherein the water-soluble composition comprises sugar alcohol.

4. The pouch according to claim 3 , wherein said sugar alcohol is selected from the group consisting of sorbitol, erythritol, xylitol, lactitol, maltitol, mannitol, hydrogenated starch hydrolysates, isomalt and any combination thereof.

5. The pouch according to claim 1 , wherein the water-soluble composition comprises sugar.

6. The pouch according to claim 1 , wherein the matrix composition further comprises a release controlling composition.

7. The pouch according to claim 6 , wherein said release controlling composition comprises one or more metallic stearates.

8. The pouch according to claim 6 , wherein said release controlling composition comprises magnesium stearate.

9. The pouch according to claim 6 , wherein said release controlling composition comprises calcium stearate.

10. The pouch according to claim 6 , wherein the matrix composition comprises said release controlling composition in an amount of between 1 and 20 percent by weight of said matrix composition.

11. The pouch according to claim 1 , wherein the pouch comprises a woven or non-woven fabric.

12. The pouch according to claim 1 , wherein the one or more cannabinoids is physically or chemically bound to at least part of the matrix composition acting as a carrier.

13. The pouch according to claim 12 , wherein the one or more cannabinoids has been granulated with the carrier.

14. The pouch according to claim 1 , wherein the matrix composition comprises said one or more cannabinoids in an amount of between 0.1 and 50 percent weight of said matrix composition.

15. The pouch according to claim 1 , wherein said one or more cannabinoids comprises cannabidiol.

16. The pouch according to claim 1 , wherein said one or more cannabinoids comprises cannabidiol in an amount of between 10 and 100 percent by weight of the one or more cannabinoids.

17. The pouch according to claim 1 , wherein said one or more cannabinoids comprises tetrahydrocannabinol.

18. The pouch according to claim 1 , wherein the one or more cannabinoids comprises tetrahydrocannabinol in an amount of between 10 and 100 percent by weight of the one or more cannabinoids.

19. The pouch according claim 1 , wherein the pouch comprises a humectant.

20. A pouch designed for administration of an active ingredient in the oral cavity, the pouch containing a water-soluble matrix composition comprising an amount of one or more cannabinoids present in granules of the water-soluble matrix composition, and wherein the one or more cannabinoids is released from the matrix composition within 10 minutes.

21. A pouch designed for administration of an active ingredient in the oral cavity, the pouch containing:

a matrix compositing comprising

one or more cannabinoids and

one or more sugar alcohols; and

a release controlling composition, and wherein the one or more cannabinoids is released from the matrix composition within 10 minutes.

22. The pouch according to claim 21 , wherein the one or more cannabinoids have been granulated with the one or more sugar alcohols.

Assignments (3)
CHANGE OF NAME Recorded Oct 1, 2020
From: MEDCAN PHARMA A/S
To: NORDICCAN A/S
Reel/Frame 053967/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2020
From: FERTIN PHARMA A/S
To: MEDCAN PHARMA A/S
Reel/Frame 052509/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2020
From: BRUUN, HEIDI ZIEGLER
To: FERTIN PHARMA A/S
Reel/Frame 052462/0796 →
Continuity (1)
Related Publication 20200179329A1 · Jun 11, 2020
Cited By (1)
US 12,263,241